Roivant Sciences (NASDAQ:ROIV) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.32) by 21.88 percent.
Telus Clocks ~10% Revenue Growth In Q3 Backed By Customer Additions; Boosts Dividend By 7.2%
Telus Corp (NYSE: TU) reported third-quarter FY22 operating revenues and other income growth of 9.9% year-on-year to CA$4.67 billion. Total telecom…